stockrow
Saturday 7 November 2026
Export LNAI’s income statement to Excel — free account
Lunai Bioworks Inc.
LNAI Healthcare Biotechnology
Lunai Bioworks Inc.’s revenue for fiscal 2026 (year ended June 2026) was $52,000.00.
- EPS
- +99.0%
- Free cash flow
- −1.65%
Quarter to June 2026, against a year earlier
0.16
0.00
0.00%
Follow LNAI
Alert me
Lunai Bioworks Inc. (LNAI) P/E ratio
Lunai Bioworks Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 185× (June 2020) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Jun 2016 | 0.0× | — |
| Dec 2015 | 0.0× | — |
Against its own ten years
Low 0.0×
High 185×
Ten-year median
0.0×
Current reading's percentile
98
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BBLG Bone Biologics Corp. compare | n/m |
| MTNB Matinas Biopharma Holdings, Inc. compare | n/m |
| SPRC SciSparc Ltd. compare | n/m |
| VBIO Valion Bio, Inc. compare | n/m |
| MLEC Moolec Science SA compare | n/m |
| JAGX Jaguar Animal Health, Inc. compare | n/m |
| BPTH Bio-Path Holdings, Inc. compare | n/m |
| ATXI Avenue Therapeutics, Inc. compare | n/m |
| LNAI Lunai Bioworks Inc. | n/m |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)